osis [ 1 - 3 ]. The somatic mutation JAK2 V617F, a single nucleotide polymorphism, is present in most patients with PV and MPNs, and in 50% of patients with ET [ 4 - 7 ]. Given the prevalence of PV and ET, which have an incidence between 38 and 57 per 100,000 people in the United States, this is quite significant [ 8 ]. In addition, those with PV and ET have a significant burden due to their hypercoagulable state with associated major thrombosis in 20% to 50% at the time of diagnosis [ 9 , 10 ]. This increased hypercoagulable state can lead to the development of portal thrombosis and hypertension, giving rise to Budd-Chiari Syndrome (BCS) [ 11 ].
← all excerpts
A 27-Year-Old Female With JAK2 Mutation: A Case of Budd-Chiari Syndrome Secondary to Prolonged Oral Contraceptive Pill Use.
1
—
—